A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis

NCT07315061 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

222

Enrollment

INDUSTRY

Sponsor class

Conditions

PsA (Psoriatic Arthritis)

Interventions

DRUG: D-2570
DRUG: Placebo

Sponsor

InventisBio Co., Ltd